119 related articles for article (PubMed ID: 8255009)
1. Effects of high-dose vitamin B6 therapy on microcytic and hypochromic anemia in hemodialysis patients.
Toriyama T; Matsuo S; Fukatsu A; Takahashi H; Sato K; Mimuro N; Kawahara H
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):975-80. PubMed ID: 8255009
[TBL] [Abstract][Full Text] [Related]
2. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
3. [Activity studies of an iron-vitamin B6 preparation for euteral treatment of iron deficiency anemia].
Reinken L; Kurz R
Int J Vitam Nutr Res; 1975; 45(4):411-8. PubMed ID: 1213868
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
Fishbane S; Lynn RI
Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
[TBL] [Abstract][Full Text] [Related]
6. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
7. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
9. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study.
Crosby L; Palarski VA; Cottington E; Cmolik B
Heart Lung; 1994; 23(6):493-9. PubMed ID: 7852064
[TBL] [Abstract][Full Text] [Related]
10. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
Saltissi D; Sauvage D; Westhuyzen J
Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
[TBL] [Abstract][Full Text] [Related]
11. [Serum ferritin as an indicator for iron substitution in patients with chronic polyarthritis].
Scherak O; Linkesch W
Z Rheumatol; 1983; 42(3):130-2. PubMed ID: 6880414
[TBL] [Abstract][Full Text] [Related]
12. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
13. Relative anemia and iron deficiency in cystic fibrosis.
Ater JL; Herbst JJ; Landaw SA; O'Brien RT
Pediatrics; 1983 May; 71(5):810-4. PubMed ID: 6835767
[TBL] [Abstract][Full Text] [Related]
14. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
Rosenlöf K; Kivivuori SM; Grönhagen-Riska C; Teppo AM; Slimes MA
Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
[TBL] [Abstract][Full Text] [Related]
15. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI
Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849
[TBL] [Abstract][Full Text] [Related]
16. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
17. Iron induced increase in red cell size in haemodialysis patients.
Gokal R; Weatherall DJ; Bunch C
Q J Med; 1979 Jul; 48(191):393-401. PubMed ID: 542585
[TBL] [Abstract][Full Text] [Related]
18. Serum ferritin and iron deficiency in patients on chronic hemodialysis.
Beallo R; Dallman PR; Schoenfeld PY; Humphreys MH
Trans Am Soc Artif Intern Organs; 1976; 22():73-9. PubMed ID: 951893
[No Abstract] [Full Text] [Related]
19. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
